Clinical Trial Update: Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating crenolanib in combination with chemotherapy versus chemotherapy alone in relapsed/refractory acute myeloid leukemia with F…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ac Acute Myeloid Leukemia
• Acute Myeloid Leukemia with Flt3 Activating Mutations

Drugs mentioned

• Chemotherapy (chemotherapy)
• Crenolanib (Crenolanib)

Snippet

Sponsor: Arog Pharmaceuticals, Inc. | Conditions: Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations | Phase 3 | Status: COMPLETED